Literature DB >> 15028071

Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers.

Renato Ricci1, Massimo Santini, Luigi Padeletti, Guiseppe Boriani, Alessandro Capucci, Gianluca Botto, Michele Gulizia, Guiseppe Inama, Antonio Galati, Francesco Solimene, Massimilano Pepe, Andrea Grammatico.   

Abstract

INTRODUCTION: New-generation pacemakers allow continuous atrial tachyarrhythmia (AT) monitoring that provides accurate information about AT type, frequency, burden, and temporary evolution. METHODS AND
RESULTS: We performed a prospective multicenter study to describe AT temporal patterns in patients with sinus bradycardia and AT. Two hundred forty patients (123 men; age 71 +/- 8 years) were implanted with a DDDRP pacemaker (model AT500, Medtronic Inc.). All patients were followed for 13 months. The first-month stabilization period of all patients was discarded from analysis. Seventy percent of patients had AT recurrences. Mean time to first AT recurrence (48.2 days, 95% confidence interval [CI] 37.0-59.5 days) was significantly longer than the time between first and second AT episode (10.3 days, 95% CI 6.7-13.9 days, P < 0.01). A minority of patients had a uniform time distribution of AT recurrences: <25% of patients had AT episodes in more than 6 of the 12 months considered in the study. The probability density function of consecutive sinus rhythm days between AT episodes was calculated for each of 40 patients who experienced >25 AT episodes and fitted by power law and exponential functions. The best fit was obtained by power law function in 60% of patients, by exponential function in 10%, and the two models gave comparable results in 30% of patients.
CONCLUSION: In our population of patients with a history of sinus bradycardia and AT who were implanted with a new device equipped with atrial pacing therapies, 30% did not experience AT recurrences in the 12-month study period. Analysis of interevent time showed that in 60% of patients AT recurrences do not follow a uniform or random distribution. These findings bring into question the use of cross-over design and time to first AT recurrence as a clinical outcome in trials for AT therapy in this patient population.

Entities:  

Mesh:

Year:  2004        PMID: 15028071     DOI: 10.1046/j.1540-8167.2004.03317.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  5 in total

1.  The impact of stored atrial rhythm diagnostics in permanent pacemakers and the management of atrial fibrillation: the Vitatron Selection AFm Registry study.

Authors:  Michael H Kim; Michael J Reiter; Robert Canby; Anthony Navone; Te-Hsin Lung; Julie Pfeiffer
Journal:  J Interv Card Electrophysiol       Date:  2010-06-04       Impact factor: 1.900

2.  Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.

Authors:  Carina Blomström-Lundqvist; Sigfus Gizurarson; Jonas Schwieler; Steen M Jensen; Lennart Bergfeldt; Göran Kennebäck; Aigars Rubulis; Helena Malmborg; Pekka Raatikainen; Stefan Lönnerholm; Niklas Höglund; David Mörtsell
Journal:  JAMA       Date:  2019-03-19       Impact factor: 56.272

3.  Pacemaker prevention therapy in drug-refractory paroxysmal atrial fibrillation: reliability of diagnostics and effectiveness of prevention pacing therapy in Vitatron selection device.

Authors:  Paolo Terranova; Paolo Valli; Peppino Terranova; Simonetta Dell'Orto; Enrico Maria Greco
Journal:  Indian Pacing Electrophysiol J       Date:  2006-04-01

4.  Atrial fibrillation and pacing algorithms.

Authors:  Paolo Terranova; Barbara Severgnini; Paolo Valli; Simonetta Dell'Orto; Enrico Maria Greco
Journal:  Indian Pacing Electrophysiol J       Date:  2006-07-01

Review 5.  The role of pacing in rhythm control and management of atrial fibrillation.

Authors:  John Silberbauer; Neil Sulke
Journal:  J Interv Card Electrophysiol       Date:  2007-05-02       Impact factor: 1.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.